Cerebroventricular administration of somatostatin (SRIF): effect on central levels of cyclic AMP.
Herchl
R
R
Department of Physiology, Faculty of Medicine, The University of Manitoba, Winnipeg, Canada.
Havlicek
V
V
Rezek
M
M
Kroeger
E
E
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004359:Drug Therapy, Combination; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D006728:Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D007276:Injections, Intraventricular; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000008:administration & dosage / Q000494:pharmacology*; D013015:Sotalol / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D006728:Hormones; D013004:Somatostatin; D013015:Sotalol; D000242:Cyclic AMP